As shown in Figure 4A, high expression of GJB2, S100A2, SPOCK2, TGM1or EPS8 indicated a poor OS of patients with ovarian cancer, whereas ovarian cancer patients with higher expression of ADAMDEC1, CHEK1, EGFL6, FAM181A, FOXA2, LYPD1, PART1 or XPR1 possessed better OS. Here, SPOCK2 is linked to ovarian carcinoma.